UNSPSC 51413300: Vasodilator prostaglandins

Vasodilator drugs made from a group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway.

UNSPSC 51413300 Vasodilator prostaglandins, a Class code, covers pharmaceutical products sourced by state and local health systems, emergency medical services, and pharmacy benefit programs. Recent state and local solicitations under this code show procurement of advanced life support medications, generic pharmaceuticals, and over-the-counter products supplied through established wholesaler networks and direct-to-manufacturer arrangements. The issuing bodies include municipal fire rescue departments, state health and human services commissions, and multi-state cooperative purchasing alliances, with activity driven by operational needs in emergency medical response and broader state pharmacy benefit administration.

Activity spans Florida, Texas, and Minnesota, with the most visible recent solicitations being the City of Tampa Fire Rescue's sealed-bid procurement (Bid No. 26-P-00188, due April 8, 2026) for four advanced life support medication line items totaling approximately $40,000 with a one-year term and renewal options; the Texas Health and Human Services Commission's Request for Information (RFI No. HHS0017013, response due April 3, 2026) exploring direct-to-manufacturer prescription fulfillment capabilities to supplement existing pharmacy benefit manager arrangements; and the Minnesota Multistate Cooperative Purchasing Alliance's Request for Proposal (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities in Minnesota and Oregon through three authorized wholesalers. The MMCAP procurement requires vendor compliance with current Good Manufacturing Practices, Drug Supply Chain Security Act certification, and competitive pricing structures, with evaluation weighted 75 percent on price competitiveness and 25 percent on administrative and operational criteria. The City of Tampa opportunity includes a Small Local Business Enterprise sheltered-market designation with a 5 percent bid discount for SLBE participation. No specific recent opportunities explicitly reference vasodilator prostaglandins as a distinct product line; activity reflects broader pharmaceutical procurement across emergency medical services and state health benefit programs.